TNFRSF4 and inflammatory bowel disease: As we would expect increased glycolysis to be reflected in elevated frequencies of activated T cells in IBD patients, levels of the early activation marker CD69 and the late activation marker CD134 were determined in IBD patients as compared to non‐IBD patients.